<DOC>
	<DOCNO>NCT02800252</DOCNO>
	<brief_summary>Therefore , aim study investigate effectiveness daily supplementation omega-3 polyunsaturated fatty acid low-dose aspirin adjunct therapy one-stage full-mouth periodontal ultrasonic debridement treatment chronic periodontitis type 2 diabetic patient superiority randomize clinical trial .</brief_summary>
	<brief_title>Effects Omega-3 Plus Low-dose Aspirin Adjunct Periodontal Debridement Chronic Periodontitis Diabetics</brief_title>
	<detailed_description>Diabetes mellitus ( DM ) become global epidemic . Its complication significant impact quality life , longevity , cost public health . The World Health Organization ( WHO ) estimate 2040 , 642 million people suffer diabetes , around 10 % world adult population ( WHO , 2015 ) . Periodontal Diseases consider sixth complication DM . This close relationship disease characterize mutual influence . Thus , appropriate control periodontal disease may facilitate DM control , improve quality life diabetic patient . Besides , presence DM might impair prognosis diverse dental treatment due inflammatory nature , negative influence wound healing , bone biology , establishment infection . As host modulatory therapy ( HMT ) , daily supplementation omega-3 polyunsaturated fatty acid low-dose aspirin propose adjunct therapy treatment chronic periodontitis , show good clinical metabolic result normoglycemic patient . Therefore , aim study investigate effectiveness daily supplementation omega-3 polyunsaturated fatty acid low-dose aspirin adjunct therapy one-stage full-mouth periodontal ultrasonic debridement treatment chronic periodontitis type 2 diabetic patient superiority randomize clinical trial .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>) Age ≥35 b ) diagnosis type 2 DM ≥5 year c ) DM treatment oral hypoglycemic agent insulin supplementation diet ) glycated hemoglobin ( HbA1c ) level 6.5 % 11 % e ) least 15 teeth ( exclude third molar teeth indicated extraction ) f ) moderate severe generalize chronic periodontitis ( Armitage , 1999 ) g ) agree sign formal consent participate study receive explanation risk benefit individual member study ( Resolution number 196 October , 1996 , Ethics Code Professional Conduct Dentistry CFO179/93 ) . ) medical condition require prophylactic antimicrobial coverage b ) scale root plan previous 6 month c ) antimicrobial therapy previous 6 month ) antiinflammatory therapy previous 6 month e ) systemic condition , DM , could affect progression chronic periodontitis f ) current use medication could interfere periodontal response treatment g ) pregnancy lactation h ) smoking</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>fatty acid</keyword>
	<keyword>aspirin</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>chronic periodontitis</keyword>
	<keyword>periodontal debridement</keyword>
</DOC>